The VARIAN-Juliana Denekamp Award established in 2005 by the European Society for Radiotherapy & Oncology (ESTRO) honours the great and dearly missed European radiobiologist Prof. Dr. Juliana Denekamp. This award is sponsored by VARIAN Medical Systems, Switzerland. In concordance with the outstanding scientific achievements of Prof. Juliana Denekamp and her enthusiasm for promoting young talents, the award will be given to young scientists (junior radiobiologists/radiotherapists) who already at a very early stage in their career have demonstrated excellence and passion for biologically driven cancer research relevant for radiation oncology, and who show promise to assume a scientific leadership role in this field in the future.

Born in 1943, Prof. Juliana Denekamp grew up in South Wales. She studied Zoology and Botany at the University of London and received her PhD at the Royal Postgraduate Medical School, Hammersmith Hospital, London, in 1968. Juliana Denekamp was a leading international scientist in radiation biology applied to radiotherapy, a field now called translational research in radiation oncology. Between 1988 and 1994 Juliana Denekamp was director of the Gray Laboratory, UK. Thereafter she was appointed as a Professor of Translational Research at the Umea University, Sweden, a position that she filled very actively both as researcher and as teacher until her much too early death in June 2001.

The VARIAN-Juliana Denekamp Award is a single prize of € 2,500, which is awarded on the occasion of the International Wolfsberg Meeting on Molecular Radiation Biology/Oncology in collaboration with ESTRO in uneven years. In 2017, the award will be presented during the 14th. International Wolfsberg Meeting to be held at Wolfsberg Castle from June 17-19, 2017.

Criteria for eligibility are:

Candidates should be ESTRO members.

Candidates should be not older than 36. Exceptions will be made for female applicants who have interrupted their research for pregnancy/maternity reasons – in this case, the maximum age is fixed at 40.

Candidates should have published at least 2-3 first author, high quality publications on a particular topic in the field of biologically driven cancer research relevant for radiation oncology.

Candidates should submit curriculum vitae including a list of publications and the 2 or 3 articles published on 1 particular topic. In case the articles were not published in English, an English summary (max 2 pages) should be submitted